TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025

Safety and antiemetic efficacy of weekly administration of netupitant/palonosetron plus dexamethasone during 5 weeks of concomitant chemo-radiotherapy-the DANGER-emesis study.

Sofie S Detlefsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.